drug

ranibizumab-nuna

1 story · latest Sep 1, 2026

Status: FDA approved Sep 2021 · BLA761202
Brand: Byooviz

Relationships

Developed by Biogen

Timeline

Samsung Bioepis gets label supplement approved for Byooviz ranibizumab biosimilar

Sep 1Regulatory decisionBiogen Harrow Inc

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.